Incidence and prevalence of euthanasia in Belgium. A study using administrative data on all cases of euthanasia reported between 2002 and 2023

Jacques Wels; Natasia Hamarat

doi:10.1101/2024.10.16.24315619

Summary

Background Reported assisted dying cases have increased in countries with such legislation. In Belgium, where euthanasia was legalized in 2002, cases rose from 236 in 2003 to 3,423 in 2023. While most studies focus on occurrence rates, this study examines the magnitude of increase and the contribution of demographic changes observed over the period.

Methods We analysed complete data from the Belgian Federal Commission for the Control and Evaluation of Euthanasia (FCCEE) from 2002-2023 (N=33,604). Using Poisson regression, we calculated Rate Ratios (RR) by age, gender, region, and euthanasia characteristics. We compared estimates with a model that included demographic offsets to calculate Prevalence Rates (PR) and explored interaction effects across sub-categories.

Results The yearly RR is 1.070, while the PR is 1.054, indicating that demographic changes significantly influence the observed increase. The PR for euthanasia among females has slightly risen (PR: 1.034), while psychiatric cases remained a small proportion (PR: 1.002). Cases citing multimorbidity have increased (RR: 1.029), whereas cases related to psychiatric disorders (PR: 0.949) and deaths in care homes (PR: 0.998) have not shown significant increases. Higher prevalence is observed in the Flemish region (PR: 1.983) but the gap has narrowed over the years.

Interpretation A substantial part of the increase in euthanasia cases is attributed to demographic changes, particularly population ageing. Early increases were mainly due to the regulatory onset, while recent trends reflect a growing influence of demographic factors and regional adjustments. Considering demographic shifts is essential and long-term trends should be monitored.

Funding ERC (UHealth), FNRS-CQ

Competing Interest Statement

NH is a member of the Federal Commission for the Control and Evaluation of Euthanasia (FCCEE). She was not involved in the decision of the FCCEE to provide data for this research. JW is a member of the user committee of the Belgian Health Data Agency (HDA). Neither the FCCEE nor the HAD were involved in the research protocol, writing or publication of the study.

Funding Statement

JW reports funding from the European Research Council (ERC Starting Grant UHealth) and the Belgian National Scientific Fund (FNRS, MIS and CQ schemes). No funding was received for this study in particular.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Access and use of data was granted by the ethic committee of the Federal Commission for the Control and Evaluation of Euthanasia (FCCEE) on the 14th of May 2024. Data were used between the 1st of July 2024 and the 14th of October 2024.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

Data access is granted upon request to the Belgian Federal Commission for the Control and Evaluation of Euthanasia (FCCEE), https://consultativebodies.health.belgium.be/en/advisory-and-consultative-bodies/federal-commission-control-and-evaluation-euthanasia

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.